The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia
NCT00277550 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2016-03-04
Summary
To demonstrate the effects of tegaserod on gastrointestinal scintigraphic orocecal transit in female patients with CC and upper GI symptoms of dyspepsia
Conditions
- Constipation and Dyspepsia
Interventions
- DRUG
-
Tegaserod and Placebo
Sponsors & Collaborators
- collaborator OTHER
- lead INDUSTRY
Principal Investigators
-
Nicholas Talley, MD · Mayo Clinic
-
Michael Crowell, PhD · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
More Related Trials
-
Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method
NCT00563615 ·Status: UNKNOWN ·Phase: NA
-
An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation
NCT00139568 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation
NCT00149877 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options
NCT01281540 ·Status: TERMINATED ·Phase: PHASE4
-
Prucalopride Versus Placebo in Gastroparesis
NCT02031081 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.
NCT00141089 ·Status: COMPLETED ·Phase: PHASE3
-
Prucalopride Versus Placebo in Gastroparesis
NCT02510976 ·Status: TERMINATED ·Phase: PHASE4
-
Gastrografin in Postoperative Ileus
NCT01648972 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals
NCT02649062 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.
NCT00414024 ·Status: TERMINATED ·Phase: PHASE3
-
Dose-Responsive Effect of Polydextrose on Whole Gut Transit Time
NCT01540669 ·Status: TERMINATED ·Phase: NA
-
Chronic Ingestion of Fructooligosaccharide and Psyllium on Intestinal Transit in Women With Functional Constipation: A Randomized Crossover Trial
NCT07202481 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain
NCT00365820 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications
NCT00153127 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery
NCT00617552 ·Status: COMPLETED ·Phase: PHASE2
-
Understanding Mechanisms of Normal and Disordered Defecation
NCT03842007 ·Status: RECRUITING ·Phase: NA
-
Effect of Prucalopride in Patients With Severe Chronic Idiopathic Constipation
NCT00576511 ·Status: COMPLETED ·Phase: PHASE2
-
Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders
NCT02567175 ·Status: NO_LONGER_AVAILABLE
-
Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit Constipation
NCT07277907 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects
NCT03279341 ·Status: COMPLETED ·Phase: PHASE4
-
Lubiprostone for Treatment of Chronic Idiopathic Constipation
NCT02695719 ·Status: COMPLETED ·Phase: PHASE3
-
Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO).
NCT05724069 ·Status: COMPLETED ·Phase: PHASE2
-
A Proof of Concept Study of Pradigastat in Patients With Functional Constipation
NCT04620161 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation
NCT02784093 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation
NCT01523184 ·Status: COMPLETED ·Phase: PHASE2